In Vivo Probe-based Confocal Laser Endomicroscopy
The VA Office of Research and Development, VA North Texas Healthcare System, Research Department intends to negotiate on a sole source basis with Mauna Kea Technologies, Inc. pursuant to FAR 6.302-1; for the purchase of a Cellvizio DualBand Probe-based Confocal Laser Endomicroscopy solution for pre-clinical use on small animals. This system is a fiber-optic fluorescence laser scanning confocal microscope with 2 lasers for excitation. The fiber-optic head stage can be used as an endoscope or directly implanted into soft tissue. The DualBand system has a large set of research applications that will be used by several research groups, including cancer and angiogenesis, neurobiology, inflammation, immunology, biodistribution, and colocalization. The system will be delivered to the VA Medical Center at 4500 S Lancaster Rd, Dallas, TX 75216. The following items will be purchased for this system:
1. Item Number CDB-0001; Cellvizio Dual Band system with Confocal processor (1).
2. Item Number LP-0001; ProFlex S300/B microprobe (2).
3. Item Number LP-0004; ProFlex S650/B microprobe (1).
4. Item Number LP-0005; ProFlex S1500 microprobe (1).
5. Item Number LP-0016; NeuroPak J (1). Includes Jacketed CerboFlex Microprobe with metallic sheath, 1 box of 6 implants with caps, 1 stereo holder, 1 set of 50 screws, and 1 screwdriver.
6. Item Number LQ-0005; 3 pack of Quantikit S/Z/miniO-488 (1).
7. Item Number LQ-0006; 3 pack of Quantikit S/Z/miniO-660 (1).
8. Item Number LA-0003; NeuroPak implants kit (1).
This notice of intent is not a request for competitive proposals. However, any small business source who believes it is capable of meeting the requirement may submit a capability statement to the contracting office no later than July 25, 2014, at 3:00PM, EST. Interest, capability statements may be sent to Travis Gibbons at [email protected]. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.
Travis Gibbons
[email protected]
[email protected]
